Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including <i>VEGFA</i>, in human osteosarcoma

Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including <i>VEGFA</i>, in human osteosarcoma

Abstract BACKGROUND: Osteosarcoma is the most common primary tumor of bone. It is a highly vascular and extremely destructive malignancy that mainly affects children and young adults. The authors conducted microarray‐based comparative genomic hybridization (aCGH) and pathway analyses to gain a syste...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Jilong Yang, Da Yang, Yan Sun, Baocun Sun, Guowen Wang, Jonathan C. Trent, Dejka M. Araujo, Kexin Chen, Wei Zhang
Hōputu:	Artigo
Reo:	Ingarihi
I whakaputaina:	2011
Urunga tuihono:	https://doi.org/10.1002/cncr.26116 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.26116
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite

Genetic Amplification of the VEGF Pathway Genes Including VEGFA in Human Osteosarcoma
mā: Yang, Jilong, me ētahi atu.
I whakaputaina: (2011)

Correlation of WWOX, RUNX2 and VEGFA protein expression in human osteosarcoma
mā: Yang, Jilong, me ētahi atu.
I whakaputaina: (2013)

Recurrent LRP1-SNRNP25 and KCNMB4-CCND3 fusion genes promote tumor cell motility in human osteosarcoma
mā: Yang, Jilong, me ētahi atu.
I whakaputaina: (2014)

Proangiogenic Interactions of Vascular Endothelial MMP14 With VEGF Receptor 1 in VEGFA-Mediated Corneal Angiogenesis
mā: Han, Kyu-Yeon, me ētahi atu.
I whakaputaina: (2016)

Proangiogenic Interactions of Vascular Endothelial MMP14 With VEGF Receptor 1 in VEGFA-Mediated Corneal Angiogenesis
mā: Kyu-Yeon Han, me ētahi atu.
I whakaputaina: (2016)

<i>VEGFA</i>and<i>VEGFR2</i>Gene Polymorphisms and Response to Anti–Vascular Endothelial Growth Factor Therapy
mā: Stephanie A. Hagstrom, me ētahi atu.
I whakaputaina: (2014)

Vascular endothelial growth factor (VEGF) stimulates neurogenesis <i>in vitro</i> and <i>in vivo</i>
mā: Kunlin Jin, me ētahi atu.
I whakaputaina: (2002)

Anti-VEGF– and anti-VEGF receptor–induced vascular alteration in mouse healthy tissues
mā: Yang, Yunlong, me ētahi atu.
I whakaputaina: (2013)

Anti-VEGF– and anti-VEGF receptor–induced vascular alteration in mouse healthy tissues
mā: Yunlong Yang, me ētahi atu.
I whakaputaina: (2013)

miR-1 Inhibits Cell Growth, Migration, and Invasion by Targeting VEGFA in Osteosarcoma Cells
mā: Niu, Junjie, me ētahi atu.
I whakaputaina: (2016)

Analysis of VEGFA Variants and Changes in VEGF Levels Underscores the Contribution of VEGF to Polycystic Ovary Syndrome
mā: Almawi, Wassim Y, me ētahi atu.
I whakaputaina: (2016)

Parent of origin influences the cardiac expression of vascular endothelial growth factor (Vegfa)
mā: Chiu, Christine L, me ētahi atu.
I whakaputaina: (2013)

Cellular distribution of vascular endothelial growth factor A (VEGFA) and B (VEGFB) and VEGF receptors 1 and 2 in focal cortical dysplasia type IIB
mā: Boer, Karin, me ētahi atu.
I whakaputaina: (2008)

Cellular distribution of vascular endothelial growth factor A (VEGFA) and B (VEGFB) and VEGF receptors 1 and 2 in focal cortical dysplasia type IIB
mā: Karin Boer, me ētahi atu.
I whakaputaina: (2008)

PLA2G16 Expression in Human Osteosarcoma Is Associated with Pulmonary Metastasis and Poor Prognosis
mā: Liang, Shoulei, me ētahi atu.
I whakaputaina: (2015)

Duplicate VegfA genes and orthologues of the KDR receptor tyrosine kinase family mediate vascular development in the zebrafish
mā: Bahary, Nathan, me ētahi atu.
I whakaputaina: (2007)

Duplicate VegfA genes and orthologues of the KDR receptor tyrosine kinase family mediate vascular development in the zebrafish
mā: Nathan Bahary, me ētahi atu.
I whakaputaina: (2007)

The prognostic value of [(123)I]-vascular endothelial growth factor ([(123)I]-VEGF) in glioma
mā: Rainer, Eva, me ētahi atu.
I whakaputaina: (2018)

Spalt-Like Protein 4 (SALL4) Promotes Angiogenesis by Activating Vascular Endothelial Growth Factor A (VEGFA) Signaling
mā: Sun, Jinbo, me ētahi atu.
I whakaputaina: (2020)

Endothelial CDS2 deficiency causes VEGFA-mediated vascular regression and tumor inhibition
mā: Zhao, Wencao, me ētahi atu.
I whakaputaina: (2019)

Vascular endothelial growth factor A (VEGFA) modulates bovine placenta steroidogenesis in vitro
mā: Liza Margareth Medeiros de Carvalho Sousa, me ētahi atu.
I whakaputaina: (2012)

Endothelial CDS2 deficiency causes VEGFA-mediated vascular regression and tumor inhibition
mā: Wencao Zhao, me ētahi atu.
I whakaputaina: (2019)

Catabolic degradation of endothelial VEGFA via autophagy
mā: Neill, Thomas, me ētahi atu.
I whakaputaina: (2020)

Focal Gains of <i>VEGFA</i> and Molecular Classification of Hepatocellular Carcinoma
mā: Derek Y. Chiang, me ētahi atu.
I whakaputaina: (2008)

Genome Editing <i>VEGFA</i> Prevents Corneal Neovascularization In Vivo
mā: Zhenhai Zeng, me ētahi atu.
I whakaputaina: (2024)

VEGFA Haplotype and VEGF-A and VEGF-R2 Protein Associations with Exudative Age-Related Macular Degeneration
mā: Vilkeviciute, Alvita, me ētahi atu.
I whakaputaina: (2022)

miR-205 suppresses the proliferative and migratory capacity of human osteosarcoma Mg-63 cells by targeting VEGFA
mā: Wang, Li, me ētahi atu.
I whakaputaina: (2015)

Chamaejasmine B Induces the Anergy of Vascular Endothelial Cells to VEGFA Pro-angiogenic Signal by Autophagic Regulation of VEGFR2 in Breast Cancer
mā: Li, Qi, me ētahi atu.
I whakaputaina: (2018)

Multiple Variants in Vascular Endothelial Growth Factor (VEGFA) Are Risk Factors for Time to Severe Retinopathy in Type 1 Diabetes
mā: Hussam Al‐Kateb, me ētahi atu.
I whakaputaina: (2007)

Dioscin Reduces Vascular Damage in the Retina of db/db Mice by Inhibiting the VEGFA Signaling Pathway
mā: Wang, Jun, me ētahi atu.
I whakaputaina: (2022)

Non-proteolytic calpain-6 interacts with VEGFA and promotes angiogenesis by increasing VEGF secretion
mā: Oh, Mijung, me ētahi atu.
I whakaputaina: (2019)

Relationship between VEGFA polymorphisms and serum VEGF protein levels and recurrent spontaneous miscarriage
mā: Wassim Y. Almawi, me ētahi atu.
I whakaputaina: (2013)

Targeting the VEGF Pathway in Osteosarcoma
mā: Assi, Tarek, me ētahi atu.
I whakaputaina: (2021)

Targeting the VEGF Pathway in Osteosarcoma
mā: Tarek Assi, me ētahi atu.
I whakaputaina: (2021)

Polarised VEGFA Signalling at Vascular Blood–Neural Barriers
mā: Dragoni, Silvia, me ētahi atu.
I whakaputaina: (2018)

Hydrophobic Interactions Drive Binding between Vascular Endothelial Growth Factor-A (VEGFA) and Polyphenolic Inhibitors
mā: Perez-Moral, Natalia, me ētahi atu.
I whakaputaina: (2019)

Knockdown of TRAF3IP2 suppresses the expression of VEGFA and the proliferation of keratinocytes and vascular endothelial cells
mā: Song, Yali, me ētahi atu.
I whakaputaina: (2019)

Induction of VEGFA and Snail-1 by meningitic <i>Escherichia coli</i> mediates disruption of the blood-brain barrier
mā: Ruicheng Yang, me ētahi atu.
I whakaputaina: (2016)

Neoadjuvant multidrug chemotherapy including High-Dose Methotrexate modifies VEGF expression in Osteosarcoma: an immunohistochemical analysis
mā: Rossi, Barbara, me ētahi atu.
I whakaputaina: (2010)

Effect of VEGF and VEGF Trap on vascular endothelial cell signaling in tumors
mā: Lassoued, Wiem, me ētahi atu.
I whakaputaina: (2010)